BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9445932)

  • 1. [Consequences of cholesterol reduction in cardiovascular diseases. What costs should be allowed to prolong life a year?].
    De Faire U
    Lakartidningen; 1997 Dec; 94(49):4607-9. PubMed ID: 9445932
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of high blood cholesterol.
    Smith MD; McGhan WF
    Bus Health; 1996 Apr; 14(4):67-8, 70, 72-4. PubMed ID: 10157682
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cost-effectiveness analysis of cardiovascular disease prevention: a graded list as aid to the rational distribution of resources].
    Lindholm L; Hallgren CG; Boman K; Markgren K; Weinehall L; Ogren JE
    Lakartidningen; 1999 Jun; 96(23):2858-63, 2865-6. PubMed ID: 10405534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [What does a human life cost?].
    Carpel CG
    Lakartidningen; 2000 Aug; 97(34):3645, 3648. PubMed ID: 11036393
    [No Abstract]   [Full Text] [Related]  

  • 5. [Statins and costs of prevented death cases].
    Robberstad T
    Tidsskr Nor Laegeforen; 1997 Nov; 117(28):4131. PubMed ID: 9441454
    [No Abstract]   [Full Text] [Related]  

  • 6. [Socioeconomic aspects of therapy of cardiovascular diseases].
    Lauterbach KW
    Herz; 2000 Aug; 25(5):473-5. PubMed ID: 10992995
    [No Abstract]   [Full Text] [Related]  

  • 7. [Reduction of cholesterol and myocardial infarction. Big differences between different groups when it comes to the therapeutic effect].
    Håkansson J
    Lakartidningen; 1997 Dec; 94(49):4619, 4622-3. PubMed ID: 9445934
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cost-benefit analysis of anticholesteremic treatment].
    Tidsskr Nor Laegeforen; 1989 Aug; 109(22):2171-3. PubMed ID: 2505403
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost-effectiveness of statin medications.
    Kaplan RM; Golomb BA
    Am Psychol; 2001 Apr; 56(4):366-7. PubMed ID: 11330239
    [No Abstract]   [Full Text] [Related]  

  • 10. [SBU should investigate what is an evidence-based and cost-effective use of statins].
    Hjemdahl P; Allhammar A; Heaton C; Hulting J; Kahan T; Malmström R; Martinsson A; Rücker F; Schenck-Gustafsson K; Schwieler J; Törnerud M; Wettermark B
    Lakartidningen; 2009 Aug 5-18; 106(32-33):1992-4. PubMed ID: 19764381
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost-effectiveness of nurse practitioner management of hypercholesterolemia following coronary revascularization.
    Paez KA; Allen JK
    J Am Acad Nurse Pract; 2006 Sep; 18(9):436-44. PubMed ID: 16958775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The 4S study is analysed. Cholesterol reduction is cost-efficient].
    Jönsson B; Johannesson M; Olsson AG
    Lakartidningen; 1997 Dec; 94(51-52):4931-4. PubMed ID: 9454018
    [No Abstract]   [Full Text] [Related]  

  • 13. [Summary of the 'Cholesterol' guideline (first revision) of the Dutch College of Family Practice].
    Bonneux L
    Ned Tijdschr Geneeskd; 2000 Apr; 144(18):862-3. PubMed ID: 10816777
    [No Abstract]   [Full Text] [Related]  

  • 14. [2008 National Cardiology Guidelines: Prioritization requires consideration to other factors than scientific studies alone].
    Eklund K; Grip L; Israelsson B; Levin LA; Lindahl B; Wallentin L
    Lakartidningen; 2008 May 7-13; 105(19):1408-9; discussion 1409. PubMed ID: 18574983
    [No Abstract]   [Full Text] [Related]  

  • 15. Screening for cholesterol?
    Kerrigan P
    Practitioner; 1989 May; 233(1468):627. PubMed ID: 2513564
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cost effectiveness in the Danish health care of ezetemibe co-administration compared to simvastatin].
    Keiding H; Hildebrandt P; Alemao E; Davies GM
    Ugeskr Laeger; 2008 Jun; 170(26-32):2323-6. PubMed ID: 18570764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An interactive computer system for formulary management using cost-effectiveness analysis.
    Lee JH; Glick HA; Kinosian B; Schulman KA
    MD Comput; 1995; 12(1):59-65. PubMed ID: 7854081
    [No Abstract]   [Full Text] [Related]  

  • 18. [Basic principles of cost-benefit analysis in long-term treatment of risk factors].
    Szucs TD; Gutzwiller F
    Schweiz Med Wochenschr; 1998 Dec; 128(49):1958-64. PubMed ID: 9887476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How much do we pay for a benefit? A descriptive cost analysis of the use of statins. The need for a national cost-effectiveness analysis.
    Vieira JL; Portal VL; Moriguchi EH
    Arq Bras Cardiol; 2001 May; 76(5):409-18. PubMed ID: 11359190
    [No Abstract]   [Full Text] [Related]  

  • 20. [New lower cholesterol levels: How much does it cost? Who is to pay?].
    Lindberg M
    Ugeskr Laeger; 2004 Nov; 166(49):4493-4; author reply 4494. PubMed ID: 15626108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.